Centre d'Oncologie et de Radiothérapie du Pays-Basque
About Centre d'Oncologie et de Radiothérapie du Pays-Basque
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Centre d'Oncologie et de Radiothérapie du Pays-Basque
During the past decade, Centre d'Oncologie et de Radiothérapie du Pays-Basque conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Docetaxel or Paclitaxel in Treating Women With Unresectable Locally Advanced or Metastatic Breast Cancer
2000-05-01
Unknown status
Involved-Field Radiation Therapy in Treating Patients With Previously Untreated Stage I or Stage II Low-Grade Non-Hodgkin's Lymphoma
2001-01-01
Terminated
204
Combination Chemotherapy in Treating Older Patients With Non-Hodgkin's Lymphoma
2002-03-01
Completed
32
A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors
2006-09-01
2014-06-01
Completed
1,252
A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer
2008-02-12
2018-11-23
Completed
808
Follow-Up Care With or Without CEA Assessments in Patients Who Have Undergone Surgery for Stage II or Stage III Colorectal Cancer
2009-09-01
2021-06-01
Completed
1,997
A Study of a Combination of Trastuzumab and Capecitabine With or Without Pertuzumab in Patients With HER2-positive Metastatic Breast Cancer (PHEREXA)
2010-01-26
2017-08-07
Completed
452
A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer
2013-11-13
2032-12-01
Active, not recruiting
1,173
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Centre d'Oncologie et de Radiothérapie du Pays-Basque" #1 sponsor was "Federation Francophone de Cancerologie Digestive" with 4 trials, followed by "Pfizer" with 3 trials
sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "UNICANCER"
with 2 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Centre d'Oncologie et de Radiothérapie du Pays-Basque"
#1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator, "Groupe Francais De Pneumo-Cancerologie" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 8 trials.
Clinical Trials Conditions at Centre d'Oncologie et de Radiothérapie du Pays-Basque
According to Clinical.Site data, the most researched conditions in "Centre d'Oncologie et de Radiothérapie du Pays-Basque" are
"Breast Cancer" (3 trials), "Lymphoma" (2 trials), "Non-small Cell Lung Cancer" (2 trials), "Adenocarcinoma of Lung Metastatic to Brain" (1 trials) and "Adenocarcinoma of the Oesogastric Junction (Siewert Type I or II)" (1 trials). Many other conditions were trialed in "Centre d'Oncologie et de Radiothérapie du Pays-Basque" in a lesser frequency.
Clinical Trials Intervention Types at Centre d'Oncologie et de Radiothérapie du Pays-Basque
Most popular intervention types in "Centre d'Oncologie et de Radiothérapie du Pays-Basque" are "Drug" (12 trials), "Other" (5 trials), "Radiation" (4 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Docetaxel" (2 trials), "LV5FU2" (2 trials), "Pertuzumab" (2 trials), "Placebo" (2 trials) and "Trastuzumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Centre d'Oncologie et de Radiothérapie du Pays-Basque
The vast majority of trials in "Centre d'Oncologie et de Radiothérapie du Pays-Basque" are
13 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.
Clinical Trials Status at Centre d'Oncologie et de Radiothérapie du Pays-Basque
Currently, there are NaN active trials in "Centre d'Oncologie et de Radiothérapie du Pays-Basque".
undefined are not yet recruiting,
2 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in Centre d'Oncologie et de Radiothérapie du Pays-Basque,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Centre d'Oncologie et de Radiothérapie du Pays-Basque, 0 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 11 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".